TY  - GEN
AU  - Fujimori,Naoyuki
AU  - Tanaka,Naoki
AU  - Kimura,Takefumi
AU  - Sano,Kenji
AU  - Horiuchi,Akira
AU  - Kato,Naoyuki
AU  - Takahashi,Yoshiyuki
AU  - Kuribayashi,Naoya
AU  - Sugiura,Ayumi
AU  - Yamazaki,Tomoo
AU  - Joshita,Satoru
AU  - Umemura,Takeji
AU  - Matsumoto,Akihiro
AU  - Tanaka,Eiji
TI  - Long-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitus
SN  - 1865-7265
PY  - 2020///1116
KW  - Alanine Transaminase
KW  - metabolism
KW  - Aspartate Aminotransferases
KW  - Diabetes Mellitus, Type 2
KW  - complications
KW  - Dipeptidyl-Peptidase IV Inhibitors
KW  - therapeutic use
KW  - Drug Therapy, Combination
KW  - Female
KW  - Glycated Hemoglobin
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Metformin
KW  - Middle Aged
KW  - Non-alcoholic Fatty Liver Disease
KW  - Sodium-Glucose Transporter 2 Inhibitors
KW  - Sorbitol
KW  - analogs & derivatives
KW  - Sulfonylurea Compounds
KW  - Treatment Outcome
N1  - Publication Type: Case Reports; Journal Article
UR  - https://doi.org/10.1007/s12328-019-01018-1
ER  -